Related Experiment Video
Updated: Jan 7, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
Initial Outcome of Single-port Robotic Surgery for Mediastinal Tumours with 23 Cases
Daisuke Ito1, Shinji Kaneda1, Teruhisa Kawaguchi1
1Department of Thoracic Surgery, Mie University Graduate School of Medicine, Tsu-city, Mie 514-8507, Japan.
Objectives:
This study aimed to report the safety, feasibility, initial outcomes, and utility of the da Vinci SP (single-port) robotic system for mediastinal tumour resection. The primary end-points were defined as the rate of conversion to thoracotomy/sternotomy or additional ports (feasibility), and the incidence of 30-day postoperative complications classified as Clavien-Dindo grade ≥IIIa (safety).
Methods:
We retrospectively analysed data from 23 patients who underwent da Vinci SP robot-assisted mediastinal tumour resection via the subxiphoid or subcostal approaches at our institution since February 2024. The primary end-points (conversion rate and severe complication rate) and key perioperative outcomes, including surgical time, console time, blood loss, drainage duration, and length of hospital stay, were assessed.
Results:
The median operative time was 128 min and the median console time was 96 min. The median blood loss was 10 g, with a median drainage period of 1 day and a median hospital stay of 5 days. The conversion rate was 0% (0/23 cases), and the severe complication rate was 0% (0/23 cases). All patients underwent R0 resection.
Conclusions:
Our initial experience with 23 cases suggests that the da Vinci SP single-port robotic system for mediastinal tumour resection is safe and feasible, with favourable short-term postoperative outcomes. Further accumulation of cases and comparative studies with conventional multiport robotic systems, video-assisted thoracoscopic surgery (VATS), and open surgery are warranted to assess the long-term efficacy and patient prognoses.
Clinical Registration Number:
H2025-092 (Observational study to verify the results of robotic surgery in thoracic surgery).

